Effect of CYP3A5 genotypes on pharmacokinetic of tacrolimus in colombian liver transplant patients
The expression of CYP3A5 in stable liver transplant patient appeared to have the greatest influence on tacrolimus pharmacokinetics over the first 2 years posttransplant.
Authors
- Jefferson Antonio Buendía (ORCID: https://orcid.org/0000-0003-2404-6612)
- Giorgio Vasquez (ORCID: https://orcid.org/0000-0001-7489-5087)
- Andrés F. Zuluaga (ORCID: https://orcid.org/0000-0001-5656-4153)
- Luis Guillermo Toro Rendón (ORCID: https://orcid.org/0009-0009-2614-4970)
- Erica Fernanda Lindarte
Institutions
- Hospital Universitario de San Vicente Fundación (CO)
- Universidad de Antioquia (CO)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-03-11
- DOI
- https://doi.org/10.3389/fphar.2025.1505490
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00